Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan · Delayed Price · Currency is TWD 29.70
0.00 (0.00%)
Aug 19, 2026, 1:30 PM CST
TPE:6657 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -298.61 | -258.4 | -231.08 | -260.38 | -265.66 | -120.24 |
Depreciation & Amortization | 17.39 | 22.55 | 22.76 | 23.78 | 24.35 | 22.85 |
Other Amortization | 0.02 | 0.02 | 0.05 | 0.05 | 0.06 | 0.06 |
Loss (Gain) From Sale of Assets | 0.03 | 0.01 | - | 0.22 | - | - |
Stock-Based Compensation | 13.06 | 17.56 | 14.85 | 14.87 | 11.09 | 4.92 |
Other Operating Activities | -0.3 | -0.63 | -0.72 | -1.04 | -0.01 | 0.46 |
Change in Accounts Receivable | -0.05 | -0.54 | 0.08 | 0.61 | -0.79 | 0.31 |
Change in Inventory | -0.11 | -0.16 | 0.04 | -0.15 | 0.16 | -0.02 |
Change in Accounts Payable | -0.19 | 0.08 | -0.03 | -0.03 | 0.07 | 0.02 |
Change in Unearned Revenue | -2.79 | -2.68 | -0.93 | - | - | -0.04 |
Change in Other Net Operating Assets | 41.17 | -0.22 | 14.28 | -2.97 | -2.12 | -5.6 |
Operating Cash Flow | -200.23 | -222.41 | -180.71 | -225.05 | -232.84 | -97.29 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -3.08 | -2.31 | -0.75 | -0.84 | -6.45 | -8.9 |
Sale (Purchase) of Intangibles | -0.02 | -0.02 | - | - | -0.14 | - |
Investment in Securities | 380 | 95.47 | 192.11 | -58.11 | 182 | -107 |
Other Investing Activities | -0.22 | -1.32 | 1.87 | - | 0 | 0.13 |
Investing Cash Flow | 376.68 | 91.83 | 193.23 | -58.96 | 175.42 | -115.76 |
Long-Term Debt Repaid | - | -6.07 | -6.2 | -6.52 | -6.51 | -6.79 |
Net Debt Issued (Repaid) | -6.14 | -6.07 | -6.2 | -6.52 | -6.51 | -6.79 |
Issuance of Common Stock | 1.94 | 434.29 | 151.49 | 446.94 | 4.75 | 294.65 |
Repurchase of Common Stock | -39.59 | -28.89 | - | - | - | - |
Other Financing Activities | - | - | - | - | - | 0.13 |
Financing Cash Flow | -43.79 | 399.34 | 145.29 | 440.42 | -1.75 | 287.98 |
Foreign Exchange Rate Adjustments | 0.33 | -0.16 | 0.09 | - | - | - |
Net Cash Flow | 132.99 | 268.6 | 157.9 | 156.41 | -59.18 | 74.94 |
Free Cash Flow | -203.31 | -224.72 | -181.47 | -225.89 | -239.29 | -106.18 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2661.10% | -2928.30% | -2341.79% | -3155.81% | -3255.16% | -1417.84% |
Free Cash Flow Per Share | -2.30 | -2.54 | -2.38 | -3.14 | -3.59 | -1.77 |
Levered Free Cash Flow | -126.59 | -131.5 | -110.26 | -129.83 | -148.4 | -57.24 |
Unlevered Free Cash Flow | -126.29 | -131.21 | -110.13 | -129.69 | -148.27 | -57.06 |
Cash Interest Paid | 0.46 | 0.46 | 0.21 | 0.21 | 0.21 | 0.28 |
Cash Income Tax Paid | 0.63 | 0.63 | 0.85 | 0.53 | -0.09 | -0.06 |
Change in Working Capital | 68.25 | -3.51 | 13.43 | -2.55 | -2.67 | -5.33 |